Calidi Biotherapeutics, Inc. (CLDI)
0.1952
-0.02
(-7.27%)
USD |
NYAM |
May 11, 14:50
Calidi Biotherapeutics Shareholders Equity (Quarterly) : 3.759M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| DiaMedica Therapeutics, Inc. | 47.24M |
| IN8bio, Inc. | 22.78M |
| ACADIA Pharmaceuticals, Inc. | 1.248B |
| Alnylam Pharmaceuticals, Inc. | 1.075B |
| Amgen, Inc. | 9.19B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 8.857M |
| Total Liabilities (Quarterly) | 5.098M |
| Debt to Equity Ratio | 0.6821 |
| Current Ratio | 1.590 |
| Net Debt Paydown Yield | 15.30% |